A Phase I Study of GZR18 Injection in Healthy Subjects
NCT06548997
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
57
Enrollment
INDUSTRY
Sponsor class
Conditions
Type 2 Diabetes
Overweight and Obesity
Interventions
DRUG:
GZR18
OTHER:
Placebo
Sponsor
Gan and Lee Pharmaceuticals, USA